This Web Site is committed to the memory of Janis Morrow.

Human liver   

Cirrhosis

 


ALL ABOUT CIRRHOSIS

Jump To Cirrhosis News:

2009 Research

2008 Research   2007 Research

2006 Research    2005 Research  

2004-2001 Research Archives


Articles on Cirrhosis

Video: Management of Hepatitis C in the Pre-Transplant Patient

GETTING RID OF CIRRHOSIS


Watch a video:  Diet and Cirrhosis


HealthWise: Cirrhosis


HALT-C Formula for Predicting Cirrhosis


Symptoms

You may not have signs and symptoms of cirrhosis in the early stages of the disease. But as more scar tissue replaces healthy tissue and liver function declines, you may experience some of the following:

  • Lack of appetite

  • Weight loss

  • Nausea

  • Small, red spider veins under your skin or easy bruising

  • Weakness

  • Fatigue

  • Yellowing of your skin and eyes and dark, cola-colored urine

  • Bleeding from engorged veins in your esophagus or intestines

  • Loss of interest in sex

  • Fluid in your abdominal cavity (ascites)

  • Itching on your hands and feet and eventually on your entire body

  • Swelling of your legs and feet from retained fluid (edema)

  • Mental confusion, such as forgetfulness or trouble concentrating (encephalopathy)


Articles


HealthWise: Cirrhosis

HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial -

M1032 - The occurrence of malignancy in patients with liver cirrhosis-more than HCC

Metabolics/Belly Fat Advance HCV Disease

The Effect of Liver Fibrosis and Cirrhosis on SVR in 4913 Patients with Hepatitis C: Results from the Win-R Trial -

Retreatment with Peginterferon Alfa-2a (Pegasys) Plus Ribavirin of Nonresponders with Cirrhosis/Advanced Fibrosis to Peginterferon Alfa-2b (PegIntron)

Coffee and tea intake may lower chronic liver disease risk

Most chronic hepatitis C sufferers will develop cirrhosis in later life

Peginterferon Alfa-2b Plus Ribavirin Elicits Sustained Response in Decompensated HCV Patients

Milk Thistle: Effects on Liver Disease and Cirrhosis and Clinical Adverse Effects

Care of the Cirrhotic Patient

Treatment of HCV in Cirrhotic Patients 

Dispelling myths in the treatment of hepatic encephalopathy

Response to Hepatitis C Therapy Can Last for Years

Articles of Interest:

ABC of diseases of liver, pancreas, and biliary system: Portal hypertension-1: varices

Cirrhosis and Chronic Liver Failure Diagnosis and Evaluation

Cirrhosis and Chronic Liver Failure Complications and Treatment


Management of Hepatitis C in the Pre-Transplant Patient

GETTING RID OF CIRRHOSIS

Researchers in France studied 96 Hep C patients with early cirrhosis (stage Child's A), proven by biopsies. They all received treatment, and 36.4% achieved an SVR. A 2nd biopsy and further follow up showed that getting rid of the virus “provides enormous benefit in terms of survival and prevention of liver-related events.” Even so, liver related events, (ascites, encephalopathy, variceal bleeds, peritonitis, liver cancer or death from liver origin) did occur in about 10% of cases, even in responders, and in about 40% among the non-responders. Three of the sustained responders did not get rid of their cirrhosis, and developed liver cancer. There were no deaths among patients whose cirrhosis was reversed during the 10 years of f follow up.

Source: www.natap.org/2008/EASL/EASL_78.htm 

http://www.hepcbc.ca/bulletin/2008/2008-09%5B1%5D.pdf 

 


ALL ABOUT CIRRHOSIS


Page One


Symptoms of Cirrhosis

“How will I know if I get cirrhosis?

Risk Factors in People with Chronic Hepatitis

Natural History of Cirrhosis

Natural History Of Compensated Cirrhosis

Natural history of decompensated hepatitis C virus-related cirrhosis.

A study of 200 patients


Page Two


Spleen Removal Can Help Hepatitis C Patients with Cirrhosis Tolerate Treatment

Spleen?
Do we need it?

Issues in Cirrhosis


Page Three


What is cirrhosis of the liver?

Important Information for Patients with Chronic Liver Disease and/or Cirrhosis

Complications of Cirrhosis: Clinical Perspectives and Implications 


Page Four


Physical Finding  Suggestive of Cirrhosis (with photos)

Page Five


Complications of Cirrhosis
 

Page Six


More on Compensated Liver disease
Cirrhosis--A Liver Problem
Treatment of Chronic Hepatitis C in Decompensated Cirrhotics

Page Seven


Hepatitis C and Liver Transplantation.
Natural history and predictors of disease progression
Prophylaxis and Treatment of Recurrent Hepatitis C
Grading system for cirrhosis: the Child-Pugh score  
Staging Cirrhosis
Long-term management of cirrhosis
What Lifestyle Factors Can Help Manage Cirrhosis ?

 


Medical Problems and Cirrhosis

Page Eight


Esophageal Varices

Encephalopathy (Hepatic or Portal-systemic)

 

Ocera Therapeutics Presents Data On AST-120 In Patients With Hepatic Encephalopathy At The European Association For The Study Of Liver Disease


 

Video

2009 Annual Meeting of the European Association for the Study of the Liver*

April 22-26, 2009 | Copenhagen, Denmark

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Peter Ferenci, MD, summarizes basic understanding of hepatic encephalopathy and data on new management options

 

http://www.clinicaloptions.com


Cirrhosis-Blood Pressure Link Studied
Management of Bleeding in the Cirrhotic Patient
Reducing Salt for Edema, Advanced Cirrhosis or Ascites
 

Small esophageal varices in cirrhotic patients

Cirrhosis and Bleeding: The Need for Very Early Management

 

Do Ammonia Levels Correlate with Hepatic Encephalopathy?

Antibiotic prophylaxis after variceal hemorrhage reduces incidence of early
rebleeding.

Normal protein diet for episodic hepatic encephalopathy

Hepatic Encephalopathy

Screening for Varices in Patients With Cirrhosis:
Where Do We Stand?


Page Nine


Maintenance Therapies for Hepatitis C

Future Trends of HCV-related Cirrhosis and Hepatocellular Carcinoma in Greece after Adjusting for Access to Peginterferon and Ribavirin

A Sustained Viral Response Predicts a Significant Decrease in Clinical Complications Among Patients with Advanced Fibrosis or Cirrhosis

Pegasys Plus Ribavirin Is Safe and Effective Treatment for Patients with Chronic Hepatitis C and Compensated Cirrhosis


Medications and Help for Patients with Cirrhosis         

Page Ten


Medication Effective In Prevention of Variceal Bleeding

Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis

 

Future Therapies

Given the frequency, morbidity, and mortality associated with recurrent bleeding, novel drugs and interventions have been studied.

 

New Approach for Minimal Hepatic Encephalopathy?

The Benefit of Natural Therapies


Warnings for Patients who have Cirrhosis  

Page Eleven


Milk Thistle: Effects on Liver Disease and Cirrhosis and Clinical Adverse Effects

Diet And Nutrition - Could Caffeine Lower The Risk For Developing Liver Cirrhosis?

Heavy Alcohol Use Greatly Increases Cirrhosis Risk in Hepatitis C-Infected Patients
Manufacturers Appeal Germany's Kava Kava Ban
Women Pay Heavy Price for Alcohol Abuse
Warnings :Celebrex And Vioxx
Threat From the Ocean
Testimony on Acetaminophen Use and Liver Injury

 

2008 Research   2007 Research

2006 Research    2005 Research  

2004-2001 Research Archives

 

 


copyright © 2003-2008 Janis and Friends Hepatitis C Web Site|  design )by carter

Design downloaded from Zeroweb.org: Free website templates, layouts, and tools.